Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine or Sugammadex - Trial NCT05545280
Access comprehensive clinical trial information for NCT05545280 through Pure Global AI's free database. This Phase 4 trial is sponsored by The Cleveland Clinic and is currently Not yet recruiting. The study focuses on Neuromuscular Blockade. Target enrollment is 286 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The Cleveland Clinic
Timeline & Enrollment
Phase 4
Dec 01, 2022
Feb 01, 2025
Primary Outcome
Urinary retention
Summary
The investigators propose a randomized trial comparing sugammadex and neostigmine for the
 reversal of neuromuscular blocks induced by rocuronium or vecuronium in adults having general
 anesthesia with muscular block for hip and knee orthopedic surgery.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05545280
Non-Device Trial